Loading…
Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials
Highlights•RZV efficacy against HZ or PHN was similar in women and men. •In ≥50-year-olds, efficacy against HZ was 95.7–97.2% across geographic regions. •In ≥70-year-olds, efficacy against HZ and PHN was 86.8–100% across geographic regions. •No major efficacy differences observed against HZ and PHN...
Saved in:
Published in: | Vaccine 2019-10, Vol.37 (43), p.6262-6267 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights•RZV efficacy against HZ or PHN was similar in women and men. •In ≥50-year-olds, efficacy against HZ was 95.7–97.2% across geographic regions. •In ≥70-year-olds, efficacy against HZ and PHN was 86.8–100% across geographic regions. •No major efficacy differences observed against HZ and PHN by geographic ancestry/ethnicity. •RZV efficacy against HZ and PHN in these subsets was consistent with the overall ZOE-50/70 population. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2019.09.028 |